This inventor holds 1 USPTO granted patent. Top assignees: Regents of the University of Minnesota, University of California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: The Innovative Contributions of Jian Tang
Introduction
Jian Tang is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. His work exemplifies the intersection of innovation and practical application in medical science.
Latest Patents
Jian Tang holds a patent for "Compounds that degrade kinases and uses thereof." This patent is directed to compounds of the Formula (I) or (II): A-L-B, A'-L-B, or a pharmaceutically acceptable salt, polymorph, prodrug, solvate, or clathrate thereof. In this formula, A represents an Aurora A ligand, A′ is a CDK4/6 ligand, B is an E3 ligase ligand, and L is a linker. The patent also includes pharmaceutical compositions comprising such compounds and methods for treating cancer using these innovative compounds. He has 1 patent to his name.
Career Highlights
Throughout his career, Jian Tang has worked with esteemed institutions such as the Regents of the University of Minnesota and the University of California. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical field.
Collaborations
Jian Tang has collaborated with notable colleagues, including Daniel A. Harki and Ramkumar Moorthy. These partnerships have further enhanced his research capabilities and have led to significant advancements in his field.
Conclusion
Jian Tang's innovative work in developing compounds for cancer treatment showcases his dedication to advancing medical science. His contributions are a testament to the importance of research and collaboration in the pursuit of effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile